MiR-449a suppresses CRIP2 expression, which then leads to increased tumor formation (as well as migration and invasion), along with the activation of proangiogenic cytokines such as VEGF, possibly via the NF-κB/p65 complex. The gene discussed is NFKB1; the disease is neoplasm.